United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - amoxicillin trihydrate; potassium clavulanate - oral tablet - 250mg ; 125mg

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - clavulanic acid, quantity: 11.4 mg/ml; amoxicillin, quantity: 80 mg/ml - oral liquid, powder for - excipient ingredients: silicon dioxide; succinic acid; colloidal anhydrous silica; aspartame; xanthan gum; hypromellose; flavour - augmentin duo 400 oral suspension is indicated in the short term treatment of the following bacterial infections when caused by sensitive organisms (see microbiology). skin and skin structure infections: urinary tract infections (complicated and uncomplicated): upper respiratory tract infections including sinusitis, otitis media: lower respiratory tract infections including acute exacerbations of chronic bronchitis and community acquired pneumonia. appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to augmentin. however, when there is good reason to believe an infection may involve any of the beta-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptible studies. once these results are known, therapy should be adjusted if appropriate. the treatment of mixed infections caused by amoxycillin susceptible organisms and beta-lactamase producing organisms susceptible to augmentin duo 400, should not require the addition of another antibiotic due to the amoxycillin content of augmentin duo 400.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline pharmaceutical sdn. bhd. - amoxycillin trihydrate; potassium clavulanate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline pharmaceutical sdn. bhd. - amoxycillin trihydrate; potassium clavulanate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline pharmaceutical sdn. bhd. - amoxycillin; potassium clavulanate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline pharmaceutical sdn. bhd. - amoxycillin; potassium clavulanate -

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - amoxycillin trihydrate 229.58mg/5ml eqv amoxycillin; potassium clavulanate 33.95mg/5ml eqv clavulanic acid - powder, for suspension - 200 mg/5 ml - amoxycillin trihydrate 229.58mg/5ml eqv amoxycillin 200 mg/5 ml; potassium clavulanate 33.95mg/5ml eqv clavulanic acid 28.5 mg/5 ml

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - amoxycillin trihydrate 459.17mg/5ml eqv amoxycillin; potassium clavulanate 67.9mg/5ml eqv clavulanic acid - powder, for suspension - 400 mg/5 ml - amoxycillin trihydrate 459.17mg/5ml eqv amoxycillin 400 mg/5 ml; potassium clavulanate 67.9mg/5ml eqv clavulanic acid 57 mg/5 ml

Ireland - English - HPRA (Health Products Regulatory Authority)

lexon pharmaceuticals (ireland) limited - amoxicillin trihydrate; clavulanic acid - film-coated tablet - 875/125 milligram(s) - combinations of penicillins, incl. beta-lactamase inhibitors; amoxicillin and enzyme inhibitor

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - amoxicillin sodium 1060.2mg equivalent to amoxicillin 1000 mg;  ; potassium clavulanate 238.25mg equivalent to clavulanic acid 200 mg;  ;  ;   - powder for injection - 1.2 g - active: amoxicillin sodium 1060.2mg equivalent to amoxicillin 1000 mg   potassium clavulanate 238.25mg equivalent to clavulanic acid 200 mg       - augmentin is indicated for the short term treatment of common bacterial infections such as: -upper respiratory tract infections (including ent): e.g. tonsillitis, sinusitis, otitis media -lower respiratory tract infections: e.g. acute exacerbations of chronic bronchitis, lobar and broncho-pneumonia -genito-urinary tract infections: e.g. cystitis, urethritis, pyelonephritis, female genital infections -skin and soft tissue infections -bone and joint infections: e.g. osteomyelitis -other infections: e.g. septic abortion, puerperal sepsis, intra-abdominal sepsis, septicaemia, peritonitis, post-surgical infections augmentin is indicated for prophylaxis against infection which may be associated with major surgical procedures such as gastro-intestinal, pelvic, head and neck, cardiac, renal, joint replacement and biliary tract surgery.